INS and Insulin resistance: CER produced de novo (especially C16 and C18 CER species) have been well described as playing a crucial role in the development of tissue insulin resistance through targeting several components of the insulin signaling pathway, including insulin receptor substrates (IRS) and Akt [92,93] (Figure 2).